Alerje, Inc.
Kalamazoo, MI Doing business as Alerje
- UEI
- EUMDHG95GMN1
- CAGE
- 84GW9
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 229 E Michigan Ave Suite 335, Kalamazoo, MI 49007, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| ANN innovative emergency medical tool for the opioid epidemic powered by artificial intelligence | Air Force Research Laboratory | $74,943 | |
| Sbir phase II: a digital platform to support food allergy oral immunotherapy treatments -the broader/commercial impact… | National Science Foundation | $1,199,997 | |
| Sbir phase i: food allergy management platform | Division of Industrial Innovation | $255,331 |
About Alerje, Inc.
Alerje, Inc., doing business as Alerje, is a minority-owned, self-certified small disadvantaged business located in Detroit, Michigan. The company develops innovative healthcare technologies, particularly focused on solutions for managing food allergies and related conditions.
Through federal contract awards, Alerje has provided research and development services to agencies like the Department of the Air Force Materiel Command Research Laboratory. Under the Small Business Innovation Research (SBIR) Program, the firm secured a $74,943 Phase I contract to develop an AI-powered emergency medical tool to combat the opioid epidemic. This firm-fixed price purchase order, awarded through a total small business set-aside, required Alerje to deliver an innovative solution leveraging artificial intelligence to address the public health crisis caused by opioid misuse and overdoses.
Alerje has also received significant federal grant funding to advance its food allergy management platform. The National Science Foundation (NSF) awarded the company a $1 million Cooperative Agreement under the Technology, Innovation, and Partnerships program. This funding supports the development of a comprehensive digital platform encompassing a HIPAA-compliant database, machine learning capabilities, web-based applications for healthcare providers, and an integrated epinephrine auto-injector device with a smartphone app. The goal is to improve patient adherence to oral immunotherapy treatments, enable remote monitoring, and facilitate clinical research on food allergies and associated treatments. Additionally, the NSF's Division of Industrial Innovation provided a $255,331 Project Grant to Alerje through the Engineering program, furthering the company's work on its food allergy management platform from July to December 2021.
Quick answers
What is Alerje, Inc.'s UEI?
Alerje, Inc.'s Unique Entity ID (UEI) in SAM.gov is EUMDHG95GMN1.
What is Alerje, Inc.'s CAGE code?
Alerje, Inc.'s CAGE code is 84GW9.
What is Alerje, Inc.'s primary NAICS code?
Alerje, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Alerje, Inc. located?
Alerje, Inc.'s physical address in SAM.gov is 229 E Michigan Ave Suite 335, Kalamazoo, MI 49007, USA.
Is Alerje, Inc. registered in SAM.gov?
Yes. Alerje, Inc.'s SAM.gov registration is active through July 17, 2027.
What is Alerje, Inc.'s most recent federal award?
Alerje, Inc.'s most recent federal contract award is ANN innovative emergency medical tool for the opioid epidemic powered by artificial intelligence (FA864924P0327), from Air Force Research Laboratory, on December 11, 2023.
On GovTribe
See Alerje, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors